There is no single best painkiller for fibromyalgia, and the medications that work are probably not what you’d expect. Standard painkillers like ibuprofen and opioids are largely ineffective because fibromyalgia pain doesn’t come from tissue damage or inflammation. Instead, the most effective medications are certain antidepressants and anticonvulsants that change how your nervous system processes pain signals.
Why Common Painkillers Don’t Work
Fibromyalgia is driven by a phenomenon called central sensitization: your brain and spinal cord amplify pain signals, making you feel more pain from the same stimulus than someone without the condition. Brain imaging studies confirm this. When researchers applied identical pressure to people with and without fibromyalgia, those with fibromyalgia showed significantly greater activation in the brain’s pain-processing areas.
The core problem is a chemical imbalance in the central nervous system. People with fibromyalgia have elevated levels of excitatory brain chemicals (like glutamate and substance P) that ramp up pain signals, and reduced levels of serotonin and norepinephrine, which normally help dampen pain. This is why anti-inflammatory drugs like ibuprofen and naproxen don’t provide meaningful relief. They target inflammation at the site of pain, but in fibromyalgia, the pain signal itself is being distorted before it reaches your conscious awareness. Opioids are equally unhelpful. Fibromyalgia involves altered opioid receptor activity in the brain, and clinical evidence consistently shows that opioid users with fibromyalgia have worse outcomes in physical function, fatigue, and emotional wellbeing compared to those who avoid them. No major guidelines recommend opioids for this condition.
The Three FDA-Approved Options
Only three medications have been specifically approved for fibromyalgia in the United States. All three work by modifying nerve signaling in the brain and spinal cord rather than treating pain at its source. None of them eliminates pain entirely, but each can reduce it enough to improve daily function for some people.
Duloxetine (Cymbalta)
Duloxetine is an antidepressant that boosts serotonin and norepinephrine, the two chemicals that are deficient in fibromyalgia’s descending pain-suppression pathways. It’s often a first choice because it can address pain, fatigue, and the mood disruption that commonly accompanies fibromyalgia. The typical starting dose is around 30 to 60 mg daily. One drawback: it can cause weight gain in some people, which is worth discussing with your prescriber since many fibromyalgia patients already struggle with weight changes from reduced activity.
Pregabalin (Lyrica)
Pregabalin is an anticonvulsant that reduces the release of excitatory neurotransmitters, essentially turning down the volume on overactive nerve signals. Clinical data shows it improves pain at doses of 300 mg daily and above, but real-world prescribing tells a different story. A study of actual prescribing patterns found that 89% of patients receiving pregabalin were prescribed less than 300 mg per day, and 35% started below 150 mg. This means many people may not be getting a therapeutic dose, which could explain why some feel the drug “doesn’t work.” If you’ve tried pregabalin without benefit, it’s worth asking whether your dose was within the effective range.
Pregabalin is also associated with weight gain, along with drowsiness and dizziness, particularly when starting or increasing the dose.
Milnacipran (Savella)
Milnacipran works similarly to duloxetine by increasing serotonin and norepinephrine, but with a stronger emphasis on norepinephrine. The typical starting dose is around 50 mg twice daily. Its key advantage is that it has not been linked to weight gain, making it a practical alternative if weight is a concern. It tends to be prescribed less often than the other two, but for the right person, it can be the better fit.
Off-Label Medications That Help
Several medications not officially approved for fibromyalgia are widely used because they target the same neurological pathways. In some cases, they have decades of clinical use behind them.
Amitriptyline, a tricyclic antidepressant, is one of the oldest and most commonly prescribed off-label options. It’s taken at much lower doses for pain than for depression, typically starting at 10 mg and increasing gradually up to 50 to 125 mg. It’s usually taken in the early evening because it causes drowsiness, which can actually be a benefit for fibromyalgia patients who struggle with sleep. The pain relief is dose-dependent, so finding the right level takes patience and gradual adjustment.
Gabapentin is closely related to pregabalin and works through a similar mechanism. The effective dose range is typically 900 to 1,200 mg daily, split into three doses, starting low at 300 mg and increasing weekly. It has less clinical evidence behind it than pregabalin for fibromyalgia specifically, but it also carries a lower risk of misuse and is often more affordable.
Low-Dose Naltrexone: A Newer Option
Low-dose naltrexone (LDN) has gained attention as an off-label treatment for fibromyalgia. Naltrexone is traditionally used at higher doses for addiction, but at very low doses (typically 1 to 5 mg, though doses up to 9 mg are used in practice), it appears to reduce neuroinflammation and modify pain processing. In a randomized, placebo-controlled trial, 45% of women taking low-dose naltrexone reported a 30% or greater reduction in pain, compared to 28% in the placebo group. That’s a meaningful gap, though it also means more than half of participants didn’t reach that threshold. LDN is not widely prescribed yet, and finding a provider familiar with it can take some effort, but it’s an option worth knowing about if standard medications haven’t worked for you.
Physical Activity Comes First in Guidelines
The most current clinical guidelines, including a 2025 update from France’s national health authority, place physical activity as the first-line treatment for fibromyalgia, ahead of any medication. This isn’t the vague advice to “just exercise more” that frustrates many patients. The guidelines specifically call for personalized physical activity programs, self-management strategies, and support for staying in the workforce. Medications are positioned as second-line treatment, to be considered only after physical activity and self-management have been tried and assessed.
This hierarchy exists because exercise directly addresses central sensitization. Regular aerobic activity increases the body’s natural pain-suppressing chemicals and can gradually recalibrate the nervous system’s pain response. For many people, the combination of consistent movement plus medication produces better results than either approach alone.
How to Choose the Right Medication
Since no single drug works for everyone, choosing a fibromyalgia medication is largely about matching side effect profiles to your specific situation. If poor sleep is your biggest secondary problem, amitriptyline’s sedating effect might be an advantage. If you’re concerned about weight gain, milnacipran is the safest bet among the approved options. If you have co-existing anxiety, pregabalin’s calming properties could pull double duty. If depression accompanies your pain, duloxetine addresses both.
Whatever medication you try, expect a slow start. Fibromyalgia drugs are typically begun at low doses and increased gradually to minimize side effects. The guidelines emphasize that a medication should only be continued if it produces a demonstrable improvement in daily function, not just a modest dip in pain scores. If one drug doesn’t help after reaching an adequate dose, switching to a different class is a reasonable next step. Many people cycle through two or three medications before finding the one that provides meaningful relief.
It’s also worth noting that “best” in fibromyalgia management rarely means pain-free. A realistic goal is reducing pain enough to sleep better, move more, and participate in the activities that matter to you. The medications that accomplish this vary widely from person to person, which is why treatment is scaled and personalized rather than one-size-fits-all.